Retinal diseases, which can lead to significant vision loss, are complex conditions involving various cellular and molecular mechanisms. The interleukin-6 (IL-6) family, particularly Oncostatin M (OSM), has garnered attention for their roles in retinal inflammation, angiogenesis, and neuroprotection. This comprehensive review explores the dual nature of OSM and other IL-6 family members in retinal pathophysiology, highlighting their contribution to both degenerative and regenerative processes. The review also examines current research on OSM’s interaction with key signaling pathways and discusses the potential of OSM and the IL-6 family as potential therapeutic targets. Understanding these mechanisms could lead to innovative treatments that modulate OSM activity, offering new avenues for managing retinal diseases and contributing to the development of more effective interventions.
The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: a comprehensive review / Mori, Tommaso; Nagaraj, Nareshkumar Ragavachetty; Surico, Pier Luigi; Zhou, Wenjing; Parmar, Uday Pratap Singh; D'Esposito, Fabiana; Gagliano, Caterina; Musa, Mutali; Zeppieri, Marco. - In: OPEN LIFE SCIENCES. - ISSN 2391-5412. - 19:1(2024), pp. 1-10. [10.1515/biol-2022-1023]
The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: a comprehensive review
Surico, Pier LuigiSecondo
;
2024
Abstract
Retinal diseases, which can lead to significant vision loss, are complex conditions involving various cellular and molecular mechanisms. The interleukin-6 (IL-6) family, particularly Oncostatin M (OSM), has garnered attention for their roles in retinal inflammation, angiogenesis, and neuroprotection. This comprehensive review explores the dual nature of OSM and other IL-6 family members in retinal pathophysiology, highlighting their contribution to both degenerative and regenerative processes. The review also examines current research on OSM’s interaction with key signaling pathways and discusses the potential of OSM and the IL-6 family as potential therapeutic targets. Understanding these mechanisms could lead to innovative treatments that modulate OSM activity, offering new avenues for managing retinal diseases and contributing to the development of more effective interventions.| File | Dimensione | Formato | |
|---|---|---|---|
|
Mori_The therapeutic potential_2024.pdf
accesso aperto
Note: This work is licensed under the Creative Commons Attribution 4.0 International License
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
656.52 kB
Formato
Adobe PDF
|
656.52 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
